Patents by Inventor Michael A. Kapin

Michael A. Kapin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8710102
    Abstract: Compositions and methods for treating disorders of the outer retina with ?-adrenoceptor antagonists are disclosed.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: April 29, 2014
    Assignee: Novartis AG
    Inventors: Robert J. Collier, Jr., Michael A. Kapin, Louis DeSantis, Jr.
  • Patent number: 8158609
    Abstract: The present invention is directed to the treatment of disorders involving the accumulation of drusen, such as dry age-related macular degeneration and geographic atrophy via administration of therapeutically effective amounts of at least one monomeric or polymeric cyclodextrin.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: April 17, 2012
    Assignee: Novartis AG
    Inventors: David Allen Marsh, Robert J. Collier, Jr., Michael A. Kapin, Youqin Tian, Eliot Mark Slovin
  • Publication number: 20110160308
    Abstract: Compositions and methods for treating disorders of the outer retina with compounds that inhibit monoamine oxidase are disclosed.
    Type: Application
    Filed: July 27, 2007
    Publication date: June 30, 2011
    Applicant: ALCON RESEARCH, LTD.
    Inventors: Robert J. Collier, JR., Michael A. Kapin, John M. Yanni
  • Publication number: 20100249134
    Abstract: Compositions and methods for treating disorders of the outer retina with ?-adrenoceptor antagonists are disclosed.
    Type: Application
    Filed: June 9, 2010
    Publication date: September 30, 2010
    Applicant: ALCON, INC.
    Inventors: Robert J. Collier, Jr., Louis DeSantis, JR., Michael A. Kapin
  • Patent number: 7763619
    Abstract: Compositions and methods for treating disorders of the outer retina with compounds with 5-HT1A agonist activity are disclosed.
    Type: Grant
    Filed: July 22, 2005
    Date of Patent: July 27, 2010
    Assignee: Alcon, Inc.
    Inventors: Robert J. Collier, Jr., Michael A. Kapin, Mark R. Hellberg, Thomas R. Dean
  • Publication number: 20100168121
    Abstract: Compositions and methods for treating disorders of the outer retina with compounds with 5-HT1A agonist activity are disclosed.
    Type: Application
    Filed: March 8, 2010
    Publication date: July 1, 2010
    Applicant: ALCON, INC.
    Inventors: Robert J. Collier, JR., Michael A. Kapin, Mark R. Hellberg, Thomas R. Dean
  • Publication number: 20080103211
    Abstract: Compositions and methods for treating disorders of the outer retina with ?-adrenoceptor antagonists are disclosed.
    Type: Application
    Filed: January 4, 2008
    Publication date: May 1, 2008
    Inventors: Robert Collier, Jr., Louis Desantis, Michael Kapin
  • Publication number: 20060199868
    Abstract: Compositions and methods for treating disorders of the outer retina with ?-adrenoceptor antagonists are disclosed.
    Type: Application
    Filed: May 2, 2006
    Publication date: September 7, 2006
    Inventors: Robert Collier, Louis Desantis, Michael Kapin
  • Patent number: 7081482
    Abstract: The invention is directed to the use of ?-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina.
    Type: Grant
    Filed: November 29, 2000
    Date of Patent: July 25, 2006
    Assignee: Alcon, Inc.
    Inventors: Robert J. Collier, Jr., Louis Desantis, Jr., Michael A. Kapin
  • Publication number: 20060014782
    Abstract: Selective PDE-IV inhibitors are useful for preventing and treating angiogenic/edema related diseases and disorders.
    Type: Application
    Filed: September 11, 2003
    Publication date: January 19, 2006
    Inventors: Daniel Gamache, David Bingaman, Michael Kapin
  • Publication number: 20050277648
    Abstract: Selective PDE-IV inhibitors are useful for preventing and treating angiogenic/edema related diseases and disorders.
    Type: Application
    Filed: August 16, 2005
    Publication date: December 15, 2005
    Inventors: Daniel Gamache, David Bingaman, Michael Kapin
  • Publication number: 20050256129
    Abstract: Compositions and methods for treating disorders of the outer retina with compounds with 5-HT1A agonist activity are disclosed.
    Type: Application
    Filed: July 22, 2005
    Publication date: November 17, 2005
    Inventors: Robert Collier, Michael Kapin, Mark Hellberg, Thomas Dean
  • Publication number: 20050143468
    Abstract: The use of amfenac and derivatives, including nepafenac, to treat vascular endothelial growth factor mediated vascular disorders.
    Type: Application
    Filed: April 16, 2003
    Publication date: June 30, 2005
    Inventors: David Bingaman, Michael Kapin, Daniel Gamache, Gustav Graff, John Yanni
  • Publication number: 20040132773
    Abstract: The use of 3-benzolphenylacetic acids and derivatives, including nepafenac, to treat neurodegenerative retinal disorders is disclosed.
    Type: Application
    Filed: February 14, 2003
    Publication date: July 8, 2004
    Inventors: Daniel A Gamache, Gustav Graff, John M Yanni, Michael A Kapin
  • Publication number: 20040053939
    Abstract: Selective PDE-IV inhibitors are useful for preventing and treating angiogenic/edema related diseases and disorders.
    Type: Application
    Filed: September 11, 2003
    Publication date: March 18, 2004
    Inventors: Daniel A. Gamache, David P. Bingaman, Michael A. Kapin
  • Publication number: 20030212107
    Abstract: Methods for treating glaucoma with R-eliprodil alone and in combination with other agents for treating glaucoma are disclosed.
    Type: Application
    Filed: October 28, 2002
    Publication date: November 13, 2003
    Inventors: Michael A. Kapin, Michael V.W. Bergamini, Verney L. Sallee
  • Publication number: 20030207941
    Abstract: The use of amfenac and derivatives, including nepafenac, to treat vascular endothelial growth factor mediated vascular disorders.
    Type: Application
    Filed: April 16, 2003
    Publication date: November 6, 2003
    Inventors: David P. Bingaman, Michael A. Kapin, Daniel A. Gamache, Gustav Graff, John M. Yanni
  • Publication number: 20030207890
    Abstract: Compositions and methods for treating disorders of the outer retina with compounds with 5-HT1A against activity are disclosed.
    Type: Application
    Filed: September 9, 2002
    Publication date: November 6, 2003
    Inventors: Robert J Collier, Michael A Kapin, Mark R Hellberg, Thomas R Dean
  • Patent number: 6638976
    Abstract: The use of 3-benzolphenylacetic acids and derivatives, including nepafenac, to treat neurodegenerative retinal disorders is disclosed.
    Type: Grant
    Filed: August 13, 2001
    Date of Patent: October 28, 2003
    Assignee: Alcon, Inc.
    Inventors: Daniel A. Gamache, Gustav Graff, John M. Yanni, Michael A. Kapin
  • Publication number: 20030187072
    Abstract: The use of 3-benzolphenylacetic acids and derivatives, including nepafenac, to treat angiogenesis-related disorders, including ophthalmic angiogenesis-related disorders such as diabetic retinopathy and exudative macular degeneration, is disclosed.
    Type: Application
    Filed: February 14, 2003
    Publication date: October 2, 2003
    Inventors: Michael A. Kapin, David P. Bingaman, Daniel A. Gamache, Gustav Graff, John M. Yanni